Am J Med. 2009 Oct;122(10):896-903.

Long-term safety concerns with proton pump inhibitors.

Source

Department of Internal Medicine, University of Oklahoma, Oklahoma City, OK, USA. tauseef-ali@ouhsc.edu

Abstract

Proton pump inhibitors (PPIs) are among the most widely prescribed medications worldwide. Their use has resulted in dramatic improvements in treatment of peptic ulcer disease and gastroesophageal reflux disease. Despite an acceptable safety profile, mounting data demonstrate concerns about the long-term use of PPIs. To provide a comprehensive review regarding the concerns of long-term PPI use, a literature search was performed to identify pertinent original and review articles. Despite study shortcomings, the collective body of information overwhelmingly suggests an increased risk of infectious complications and nutritional deficiencies. Data regarding any increased risk in gastric or colon malignancy are less convincing. PPIs have revolutionized the management and complications of acid-related disorders with a high margin of safety; however, with the data available, efforts to reduce the dosing of or discontinue the use of PPIs must be reassessed frequently.

Comment in

Am J Med. 2010 Apr;123(4):e11; author reply e13.

PMID:: 19786155; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Review Considerations for long-term use of proton-pump inhibitors. [Am J Health Syst Pharm. 1998]
Review Considerations for long-term use of proton-pump inhibitors.
Garnett WR. Am J Health Syst Pharm. 1998 Nov 1; 55(21):2268-79.
Review Is there a dark side to long-term proton pump inhibitor therapy? [Am J Ther. 2008]
Review Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB, Howden CW. Am J Ther. 2008 Nov-Dec; 15(6):536-42.
Review Proton pump inhibitor side effects and drug interactions: much ado about nothing? [Cleve Clin J Med. 2011]
Review Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Madanick RD. Cleve Clin J Med. 2011 Jan; 78(1):39-49.
Review Safety of the long-term use of proton pump inhibitors. [World J Gastroenterol. 2010]
Review Safety of the long-term use of proton pump inhibitors.
Thomson AB, Sauve MD, Kassam N, Kamitakahara H. World J Gastroenterol. 2010 May 21; 16(19):2323-30.
Review Potential adverse effects of proton pump inhibitors. [Curr Gastroenterol Rep. 2008]
Review Potential adverse effects of proton pump inhibitors.
Coté GA, Howden CW. Curr Gastroenterol Rep. 2008 Jun; 10(3):208-14.

See reviews... See all...

Cited by 6 PubMed Central articles

Review Management of non-variceal upper gastrointestinal tract hemorrhage: controversies and areas of uncertainty. [World J Gastroenterol. 2012]
Review Management of non-variceal upper gastrointestinal tract hemorrhage: controversies and areas of uncertainty.
Trawick EP, Yachimski PS. World J Gastroenterol. 2012 Mar 21; 18(11):1159-65.
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings. [J Toxicol Pathol. 2010]
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.
Ettlin RA, Kuroda J, Plassmann S, Prentice DE. J Toxicol Pathol. 2010 Dec; 23(4):189-211. Epub 2010 Dec 16.
Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients. [J Gastric Cancer. 2011]
Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients.
Lim JS, Lee JI. J Gastric Cancer. 2011 Mar; 11(1):7-15. Epub 2011 Mar 31.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Long-term safety concerns with proton pump inhibitors.
Long-term safety concerns with proton pump inhibitors.
Am J Med. 2009 Oct ;122(10):896-903.

PubMed
Papillomavirus interaction with cellular chromatin.
Papillomavirus interaction with cellular chromatin.
Biochim Biophys Acta. 2010 Mar-Apr ;1799(3-4):192-9. Epub 2009 Sep 26 .

PubMed
Gamma-radiation induces micronucleated reticulocytes in 3D bone marrow bioreacto...
Gamma-radiation induces micronucleated reticulocytes in 3D bone marrow bioreactors in vitro.
Mutat Res. 2009 Nov-Dec ;680(1-2):49-55. Epub 2009 Sep 26 .

PubMed
The identification of interacting networks in the brain using fMRI: Model select...
The identification of interacting networks in the brain using fMRI: Model selection, causality and deconvolution.
Neuroimage. 2011 Sep 15 ;58(2):296-302. Epub 2009 Sep 25 .

PubMed
IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway.
IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway.
Cell Signal. 2010 Jan ;22(1):117-27. Epub 2009 Sep 25 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: